• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

QLT:CN

5.7000 CAD 0.0200 0.35%

As of 15:59:57 ET on 09/19/2014.

Snapshot for QLT Inc (QLT)

Open: 5.7400 Day's Range: 5.7000 - 5.7700 Volume: 2,191
Previous Close: 5.7200 52wk Range: 4.3300 - 7.9000 1-Yr Rtn: +18.50%

Stock Chart for QLT

No chart data available.
  • QLT:CN 5.7000
  • 1D
  • 1M
  • 1Y
5.7200
Interactive QLT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QLT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -0.5340
Est. EPS (USD) (12/2014) -0.5500
Est. PEG Ratio -
Market Cap (M CAD) 291.17
Shares Outstanding (M) 51.08
30 Day Average Volume 6,566
Price/Book (mrq) 1.8531
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 3.9153
Dividend Ex-Date 06/28/2013
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QLT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QLT

QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease. The Company's lead drug, Visudyne, is marketed by Novartis AG, and is used in the treatment of the wet form of age-related macular degeneration.

Jason M AryehChairmanSukhi JagpalChief Financial Officer
Linda M LupiniSenior VP:Human Resources
More Company Profile & Key Executives for QLT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil